22 July, 2025 | Tuesday
BioPharma Boardroom
Ordinary and Extraordinary General Meeting of April 12, 2023

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, will hold its Or...

March 26, 2023 | Sunday | News
Abcam's Rich Lane Talks Expansion in APAC Region

What are the major plans in store for the new APAC hub at Singapore? For a company like Abcam which strongly believes that collaboration is a big driver o...

March 26, 2023 | Sunday | Influencers
Enhanced traceability plays a crucial role in building a resilient biopharma supply chain

How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and business resilience?  Unpredict...

March 26, 2023 | Sunday | Influencers
ProfoundBio showcases PRO1184's antitumor activity at AACR 2023

ProfoundBio, a clinical stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential, will present t...

March 26, 2023 | Sunday | News

Partner Content

BioPharma BreakThrough's

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
  View poll results   More polls
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
BioPharma Boardroom

About Us Media Pack Contact Us Privacy Policy

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close